Research and Development Investment
First written in FY2017-Q2. 13 of 36 entries say "Restated". Latest entry: FY2027-H1.
42 other companies' latest entry also says "Other".
- FY2027-H1First-Half Decline in R&D ExpensesAnnual report
「Total R&D expenses for the interim accounting period were ¥85.350 million.」
First-half R&D expenses decreased to ¥85.350 million from ¥116.053 million in the same period of the previous year. - FY2026Decrease in R&D-related investmentAnnual report
「R&D-related investment for the current fiscal year was as follows: Total ¥261.982 million」
R&D-related investment decreased to ¥261.982 million from ¥419.826 million in the previous fiscal year. - FY2026-H1First-Half Decline in R&D ExpensesAnnual report
「Total R&D expenses for the interim accounting period were ¥116.053 million.」
First-half R&D expenses decreased to ¥116.053 million from ¥149.496 million in the same period of the previous year. - FY2025Increase in R&D-Related InvestmentsAnnual report
「R&D-related investment for the current fiscal year was as follows: Total ¥419.826 million」
R&D-related investment increased to ¥419.826 million from ¥321.590 million in the previous fiscal year. This includes interview and research expenses, personnel expenses and related costs, construction in progress and software in progress. - FY2025-H1Increase in first-half R&D expensesAnnual report
「Total R&D expenses for the interim accounting period were ¥149.496 million.」
First-half R&D expenses increased to ¥149.496 million from ¥117.115 million in the same period of the previous year. Upfront investment toward the launch of new businesses is continuing. - FY2025-Q1Increase in R&D expenses and upfront investment in new businessesAnnual report
「Total R&D expenses for the first quarter of the current fiscal year were ¥78.951 million.」
R&D expenses increased to ¥78.951 million from ¥62.173 million in the same period of the previous year. The company includes approximately ¥27 million in upfront investment and other expenses for developing new businesses in R&D expenses. - FY2024Decrease in R&D-related investmentAnnual report
「Total ¥321.590 million」
R&D-related investment decreased to ¥321.590 million from ¥436.926 million in the previous fiscal year. This includes capital expenditures for molds and other equipment, prototype costs, interview and research expenses, promotional material costs, personnel expenses and related costs. - FY2024-Q3Third-quarter R&D expenses increaseAnnual report
「Total R&D expenses for the first nine months of the current fiscal year were ¥196.176 million.」
R&D expenses for the first nine months increased to ¥196.176 million from ¥161.153 million in the same period of the previous year. - FY2024-Q2Increase in second-quarter R&D expenditureAnnual report
「Total R&D expenses for the first six months of the current fiscal year were ¥117.115 million.」
R&D expenses for the first six months increased to ¥117.115 million from ¥107.975 million in the same period of the previous year. However, the company explains that the increase was modest at the end of the second quarter because full-scale investment spending for new business development will begin in the second half and thereafter. - FY2024-Q1Increase in first-quarter R&D expenditureAnnual report
「Total R&D expenses for the first quarter of the current fiscal year were ¥62.173 million.」
First-quarter R&D expenses increased to ¥62.173 million from ¥46.955 million in the same period of the previous year. This includes approximately ¥20 million in upfront investment and other expenses for developing new businesses. - FY2023Increase in R&D-Related InvestmentsAnnual report
「Total ¥436.926 million」
R&D-related investment increased to ¥436.926 million from ¥350.431 million in the previous fiscal year. This includes capital expenditures for molds and other equipment, prototype costs, interview and research expenses, promotional material costs, personnel expenses and related costs. - FY2023-Q3Third-quarter R&D expenses declineAnnual report
「Total R&D expenses for the first nine months of the current fiscal year were ¥161 million.」
R&D expenses for the first nine months decreased to ¥161 million from ¥166 million in the same period of the previous year. - FY2023-Q2Increase in second-quarter R&D expenditureAnnual report
「Total R&D expenses for the first six months of the current fiscal year were ¥107.975 million.」
R&D expenses for the first six months increased to ¥107.975 million from ¥105.641 million in the same period of the previous year. - FY2023-Q1Decrease in first-quarter R&D expensesAnnual report
「Total R&D expenses for the first quarter of the current fiscal year were ¥46.955 million.」
First-quarter R&D expenses decreased to ¥46.955 million from ¥48.562 million in the same period of the previous year. - FY2022Significant increase in R&D-related investmentAnnual report
「Total ¥350.431 million」
R&D-related investment increased to ¥350.431 million from ¥274.666 million in the previous fiscal year. This includes capital expenditures for molds and other equipment, prototype costs, interview and research expenses, promotional material costs, personnel expenses and other costs. - FY2022-Q3Third-quarter R&D expenses increaseAnnual report
「Total R&D expenses for the first nine months of the current fiscal year were ¥167 million.」
R&D expenses for the first nine months increased to ¥167 million from ¥135 million in the same period of the previous year. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the first six months of the current fiscal year were ¥105.641 million.」
The company continues to disclose total R&D expenses for the first six months. - FY2022-Q1Increase in first-quarter R&D expenditureAnnual report
「Total R&D expenses for the first quarter of the current fiscal year were ¥48.562 million.」
First-quarter R&D expenses increased to ¥48.562 million from ¥44.198 million in the same period of the previous year. - FY2021Decrease in R&D-related investmentAnnual report
「Total ¥239.694 million」
R&D-related investment decreased to ¥239.694 million from ¥274.666 million in the previous fiscal year. - FY2021-Q3Increase in R&D ExpensesAnnual report
「Total R&D expenses for the first nine months of the current consolidated fiscal year were ¥135 million.」
R&D expenses increased to ¥135 million from ¥127 million in the same period of the previous year. - FY2021-Q2Increase in R&D ExpensesAnnual report
「Total R&D expenses for the first six months of the current consolidated fiscal year were ¥89.148 million.」
R&D expenses increased to ¥89.148 million from ¥81.330 million in the same period of the previous year. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current consolidated fiscal year were ¥44.198 million.」
The company continues to disclose total R&D expenses of ¥44.198 million for the first quarter. - FY2020Increase in R&D-Related InvestmentsAnnual report
「Total ¥274.666 million」
R&D-related investment increased to ¥274.666 million from ¥266.888 million in the previous fiscal year. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the first nine months of the current consolidated fiscal year were ¥127 million.」
The company continues to disclose total R&D expenses for the cumulative third quarter. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the first six months of the current consolidated fiscal year were ¥81.330 million.」
The company continues to disclose total R&D expenses. They increased from ¥79.034 million in the same period of the previous year. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current consolidated fiscal year were ¥40.565 million.」
The company continues to disclose quarterly R&D expenses. They increased from ¥39.039 million in the same period of the previous year. - FY2019Increase in R&D-Related InvestmentsAnnual report
「R&D-related investments for the consolidated fiscal year were as follows: Total: ¥266.888 million」
The company disclosed total R&D-related investments of ¥266.888 million, up from ¥240.546 million in the previous fiscal year. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year ended ¥122 million.」
The company continues to disclose total R&D expenses of ¥122 million. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year ended ¥79.034 million.」
The company continues to disclose total R&D expenses. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year ended ¥39.039 million.」
The company continues to disclose total R&D expenses. - FY2018RestatedAnnual report
「R&D-related investments for the consolidated fiscal year were as follows: Total: ¥240.546 million」
The company disclosed total full-year R&D-related investments of ¥240.546 million. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter ended ¥115.599 million.」
The company continues to disclose total R&D expenses for the cumulative third quarter. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter ended ¥77.353 million.」
The company continues to disclose total R&D expenses. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter ended ¥37.991 million.」
The company continues to report total R&D expenses. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter ended ¥125.584 million.」
The company updates the total R&D expenses for the cumulative third quarter. - FY2017-Q2First statedAnnual report
「Total R&D expenses for the cumulative second quarter ended ¥82.933 million.」
The company reports total R&D expenses for the cumulative second quarter.